RENAISSANCE TECHNOLOGIES LLC
Top Portfolio Positions
2,305 positions ·
$57,316,285,867 total
· as of Dec 31, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| PLTR |
Palantir Technologies Inc.
Technology
|
8,796,727 | $1,563,618,224 | 2.73% |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
1,909,259 | $930,286,447 | 1.62% |
| MU |
Micron Technology Inc
Technology
|
3,011,143 | $859,410,323 | 1.50% |
| KGC |
Kinross Gold Corp
|
24,975,313 | $703,304,814 | 1.23% |
| VRSN |
Verisign Inc/Ca
|
2,779,351 | $675,243,325 | 1.18% |
| NFLX |
Netflix Inc
Communication Services
|
7,178,287 | $673,036,189 | 1.17% |
| TSLA |
Tesla, Inc.
Consumer Cyclical
|
1,362,122 | $612,573,505 | 1.07% |
| EXEL |
Exelixis, Inc.
Healthcare
|
13,914,043 | $609,852,504 | 1.06% |
| COST |
Costco Wholesale Corp /New
Consumer Defensive
|
693,002 | $597,603,344 | 1.04% |
| CVNA |
Carvana Co.
Consumer Cyclical
|
1,407,398 | $593,950,103 | 1.04% |
Portfolio Trend
Holdings in VBNK
Export CSVShares Held
Position Value (USD)
13 of 13 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1,301,762 | 86,900 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,120,878 | 91,800 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $491,340 | 43,100 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,008,028 | 97,300 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,645,380 | 118,800 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $955,761 | 71,970 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $305,584 | 28,400 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $358,439 | 33,815 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $136,875 | 12,500 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $93,474 | 11,900 | Shares | Sole | 2023-11-14 | |
| 2022-03-31 | $336,300 | 29,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $683,060 | 57,400 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $798,553 | 72,300 | Shares | Sole | 2021-11-12 | |
| No quarters match your search. | ||||||